July 1, 2016 (Shareholders Foundation) - An investigation on behalf of investors of Emergent Biosolutions Inc (NYSE:EBS) shares over potential securities laws violations by Emergent Biosolutions and certain of its directors and officers in connection certain financial statements was announced.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Emergent Biosolutions Inc (NYSE:EBS) concerning whether a series of statements by Emergent Biosolutions regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Emergent Biosolutions Inc reported that its annual Total Revenue rose from $281.89 million in 2012 to $522.79 million in 2015 and that its Net Income increased from $23.52 million in 2012 to $62.87 million in 2015.
Shares of Emergent Biosolutions Inc (NYSE:EBS) grew from $13.20 per share in April 2013 to as high as $44.38 per share on June 7, 2016. Since then NYSE:EBS shares declined to $27.01 per share on June 28, 2016.
On July 1, 2016, NYSE:EBS shares closed at $28.71 per share.